CIPREC is a medical center specialized in clinical research with over 20 years of experience, recognized for its work in multiple therapeutic specialties. We have participated in more than 200 clinical studies and received over 40 audits from sponsors and inspections from the national regulatory authority. We have a medical team with extensive research experience, committed to excellence, ethics, and scientific advancement.

Our organization promotes a culture of continuous improvement, supported by the implementation of robust quality systems, standardized operating procedures (SOPs), and technological tools for efficient protocol management.

Our Commitments

In this context, we have defined our quality management policy by assuming the commitment to:

1. Excellence in patient care and safety

We provide high-quality medical care, based on scientific evidence, innovation, and respect for each patient.

2. Satisfaction of our stakeholders

We meet the needs of patients, employees, and sponsor companies through agile, efficient, and highly professional processes.

3. Regulatory compliance and ethical conduct

We ensure compliance with good clinical practices (GCP) and applicable national and international regulatory requirements.

4. Training and selection of highly qualified professionals

We have an interdisciplinary team with ethical and responsible leadership, composed of specialists with prestige and experience in the field of Clinical Research.

5. Risk management and continuous improvement

We monitor risks associated with our quality management, implementing preventive and corrective measures that guarantee continuous improvement of our processes and services.

6. Human talent development and innovation culture

We promote permanent training, adoption of new technologies, and a work environment based on cooperation, solidarity, creativity, and commitment to quality, ensuring close and humanistic care.

The Board of Directors of CIPREC assumes responsibility for the implementation of this policy, guaranteeing the necessary resources for its implementation, dissemination, and compliance.

Buenos Aires, April 2025
Cesar Javier Zaidman
President